Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000428 | DNA-directed RNA polymerase complex | 4 | 10 |
GO:0030880 | RNA polymerase complex | 3 | 10 |
GO:0032991 | protein-containing complex | 1 | 10 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 10 |
GO:0140535 | intracellular protein-containing complex | 2 | 10 |
GO:1902494 | catalytic complex | 2 | 10 |
GO:1990234 | transferase complex | 3 | 10 |
GO:0005666 | RNA polymerase III complex | 4 | 1 |
GO:0016020 | membrane | 2 | 1 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A4H5T5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006352 | DNA-templated transcription initiation | 6 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009058 | biosynthetic process | 2 | 10 |
GO:0009059 | macromolecule biosynthetic process | 4 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 10 |
GO:0018130 | heterocycle biosynthetic process | 4 | 10 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 10 |
GO:0032774 | RNA biosynthetic process | 5 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044249 | cellular biosynthetic process | 3 | 10 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 10 |
GO:1901576 | organic substance biosynthetic process | 3 | 10 |
GO:0006384 | transcription initiation at RNA polymerase III promoter | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 6 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
GO:0016779 | nucleotidyltransferase activity | 4 | 1 |
GO:0034062 | 5'-3' RNA polymerase activity | 5 | 1 |
GO:0097747 | RNA polymerase activity | 4 | 1 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 258 | 262 | PF00656 | 0.358 |
CLV_C14_Caspase3-7 | 290 | 294 | PF00656 | 0.429 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.447 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.458 |
DOC_CDC14_PxL_1 | 146 | 154 | PF14671 | 0.336 |
DOC_PP4_FxxP_1 | 151 | 154 | PF00568 | 0.274 |
DOC_PP4_FxxP_1 | 219 | 222 | PF00568 | 0.200 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.389 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.200 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.468 |
DOC_USP7_MATH_1 | 49 | 53 | PF00917 | 0.582 |
DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.270 |
DOC_WW_Pin1_4 | 218 | 223 | PF00397 | 0.200 |
LIG_14-3-3_CanoR_1 | 71 | 77 | PF00244 | 0.356 |
LIG_BIR_III_4 | 281 | 285 | PF00653 | 0.391 |
LIG_BRCT_BRCA1_1 | 215 | 219 | PF00533 | 0.211 |
LIG_eIF4E_1 | 140 | 146 | PF01652 | 0.336 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.427 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.473 |
LIG_FHA_1 | 266 | 272 | PF00498 | 0.200 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.432 |
LIG_FHA_2 | 61 | 67 | PF00498 | 0.366 |
LIG_LIR_Apic_2 | 216 | 222 | PF02991 | 0.200 |
LIG_LIR_Gen_1 | 144 | 154 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.291 |
LIG_LIR_Nem_3 | 3 | 8 | PF02991 | 0.341 |
LIG_MYND_1 | 150 | 154 | PF01753 | 0.391 |
LIG_PDZ_Class_3 | 290 | 295 | PF00595 | 0.643 |
LIG_Pex14_2 | 18 | 22 | PF04695 | 0.538 |
LIG_SH2_CRK | 8 | 12 | PF00017 | 0.332 |
LIG_SH2_NCK_1 | 8 | 12 | PF00017 | 0.432 |
LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.516 |
LIG_SH2_STAP1 | 8 | 12 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.381 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.326 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.362 |
LIG_SH3_3 | 115 | 121 | PF00018 | 0.399 |
LIG_SH3_3 | 13 | 19 | PF00018 | 0.413 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.391 |
LIG_SUMO_SIM_par_1 | 9 | 14 | PF11976 | 0.309 |
LIG_TRAF2_1 | 256 | 259 | PF00917 | 0.310 |
LIG_TYR_ITIM | 6 | 11 | PF00017 | 0.333 |
MOD_CDK_SPxxK_3 | 119 | 126 | PF00069 | 0.273 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.336 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.496 |
MOD_CK1_1 | 43 | 49 | PF00069 | 0.561 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.458 |
MOD_CK2_1 | 252 | 258 | PF00069 | 0.370 |
MOD_CK2_1 | 284 | 290 | PF00069 | 0.336 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.435 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.381 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.448 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.483 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.232 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.470 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.573 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.482 |
MOD_GlcNHglycan | 95 | 99 | PF01048 | 0.426 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.399 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.468 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.435 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.571 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.538 |
MOD_N-GLC_2 | 24 | 26 | PF02516 | 0.529 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.396 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.378 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.336 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.317 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.516 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.370 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.440 |
MOD_NEK2_2 | 265 | 270 | PF00069 | 0.200 |
MOD_NEK2_2 | 60 | 65 | PF00069 | 0.450 |
MOD_PKA_2 | 274 | 280 | PF00069 | 0.328 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.351 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.333 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.236 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.200 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.283 |
MOD_Plk_4 | 284 | 290 | PF00069 | 0.321 |
MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.268 |
MOD_ProDKin_1 | 218 | 224 | PF00069 | 0.200 |
MOD_SUMO_for_1 | 241 | 244 | PF00179 | 0.206 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.333 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P336 | Leptomonas seymouri | 52% | 89% |
A0A1X0NIF1 | Trypanosomatidae | 35% | 96% |
A0A3Q8I7I6 | Leishmania donovani | 82% | 99% |
A0A422MXM4 | Trypanosoma rangeli | 33% | 100% |
A4HU28 | Leishmania infantum | 81% | 99% |
E9AMV8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 99% |
Q4QHR8 | Leishmania major | 82% | 100% |
V5BI52 | Trypanosoma cruzi | 33% | 100% |